Metronidazole — Drug Intelligence | 29 EU Trials

Filter these 29 trials by condition, phase, country and more.

Open in Search →

29 Registered trials

13 Recruiting

2 Completed trials

24 Sponsors

22 Countries

Phase III

Phase II

Phase IV

Phase I (Other)

Phase III: 11 Phase II: 4 Phase I/II: 2 Phase III/IV: 1 Phase IV: 8 Phase I (Other): 3

Oversight events:

2 temporary halts 1 urgent safety measure 1 corrective measure across 3 trials

View oversight register →

Indications tested

Sepsis 2 Abdominal infection 1 Brain abscess 1 Pouchitis 1 Bacterial vaginosis 1 Bacterial infection 1 Infection 1 Urinary tract infection 1 Anal fistula 1 Diabetic foot infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 3 Region Sjaelland 3 Reponex Pharmaceuticals A/S 3 Turku University Hospital 3 Pfizer Inc. 2 Aalborg University Hospital 1 Academisch Ziekenhuis Leiden 1 Amsterdam UMC Stichting 1 Centre Hospitalier Universitaire Amiens Picardie 1 Freya Biosciences ApS 1 Friedrich-Schiller-Universitaet Jena 1 Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca 1

All trials

29 total

Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Not authorised

2024-520317-49-00 Phase I (Other) 1 country Region Sjaelland; Reponex Pharmaceuticals A/S
Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and i… Pending

2023-505500-37-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Study to Learn About the Study Medicine Called Aztreonam-Avibactam in Neonates and Infants Less Than 9 Months of Age With Suspected or Con… Pending

2023-507757-15-01 Phase II 6 countries Pfizer Inc.
AUTOP 2 : Screen-and-treat strategy for vaginal flora abnormalities by molecular biology in pregnant women at high risk of preterm birth: A … Pending

2023-509421-41-03 Phase III 1 country Assistance Publique Hopitaux De Marseille
Phase II Randomized Clinical Trial of quinacrine versus metronidazole in resistant giardiasis in children: Quin4Kids Pending

2023-510227-30-00 Phase I/II 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
ATLAS trial Pending

2024-517233-40-00 Phase IV 1 country Amsterdam UMC Stichting; Proctos kliniek
Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending

2024-518984-36-00 Phase IV 1 country Turku University Hospital
Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending

2024-519392-26-00 Phase IV 1 country Turku University Hospital
Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Pending

2024-520317-49-02 Phase I (Other) 1 country Region Sjaelland; Reponex Pharmaceuticals A/S
Clinical and economical efficiency and safety and inflammation parameter correlations study of conservative treatment of non-complicated acu… Pending

2025-520496-19-00 Phase IV 1 country Riga Stradins University
Antibiotic therapy vs. placebo in the treatment of acute uncomplicated appendicitis: a prospective randomized double-blind placebo-controlle… Pending

2025-520761-44-00 Phase IV 1 country Turku University Hospital
EPISSOC : Randomized controlled trial comparing an Early Pleural Irrigation strategy with Saline to the Standard of Care for the management … Pending

2025-524697-42-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending

2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
A Study to Evaluate a New Treatment Option for Helicobacter pylori Infection Compared to First Line Treatment. Pending

2026-525291-26-00 Phase III 1 country Verisfield Single Member S.A.
Chlorhexidine and/or metronidazole plus FB301 pre-treatment trial Recruiting

2025-524362-20-00 Phase II 1 country Freya Biosciences ApS
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
Efficacy and Safety of Vedolizumab Intravenous in Pediatric Chronic Pouchitis Recruiting

2023-504773-20-00 Phase III 8 countries Takeda Development Center Americas Inc.
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting

2022-500257-16-00 Phase III 15 countries Micurx Pharmaceuticals Inc.
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Recruiting

2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Multicenter clinical trial on the effectiveness and safety of outpatient treatment of acute uncomplicated diverticulitis without antibiotics… Recruiting

2025-523121-17-00 Phase IV 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
ORIAMI Recruiting

2023-508249-42-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradeni… Recruiting

2023-505818-16-00 Phase III 1 country Institut Pasteur
Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting

2023-506224-87-00 Phase II 1 country Mikrobiomik Healthcare Company S.L.
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Phase I/II 1 country Region Sjaelland; Reponex Pharmaceuticals A/S

Showing 1–24 of 29 trials

← All drugs A–Z